Brentuximab (Anti-TNFRSF8 / CD30)

Ask supplier a question | View on supplier's website
Brentuximab (Anti-TNFRSF8 / CD30) is a chimeric monoclonal antibody targeting anti-CD30 with antineoplastic activity. It has the potential to alter the disease course of non-MF/SS CTCLs. MW : 145.38 KD.
Supplier Selleck Chemicals
Product # A2322
Sku # A2322-1mg*5
Pricing 1mg*5, $1390.00
Feedback